Hair loss is not a commonly reported side effect of irbesartan. It does not appear as an adverse reaction in the drug’s official FDA labeling, and clinical trials did not identify it at a measurable frequency. That said, scattered reports from patients taking irbesartan and similar blood pressure medications do exist, and drug-induced hair loss is a recognized phenomenon across many medication classes.
What Clinical Data Shows
In placebo-controlled clinical trials for irbesartan (sold under the brand name Avapro), the side effects reported at higher rates than placebo were limited to fatigue (4% vs. 3%), diarrhea (3% vs. 2%), and heartburn (2% vs. 1%). Hair loss did not make the list at any frequency threshold. The FDA’s post-marketing surveillance for irbesartan, which captures rare side effects reported after a drug reaches the broader population, also does not include alopecia. Post-marketing reports focus on issues like allergic reactions, liver enzyme changes, and elevated potassium levels.
This doesn’t mean zero people have experienced hair thinning while taking irbesartan. It means that if it happens, it’s rare enough that it hasn’t shown up as a pattern in formal tracking systems. For comparison, the most common side effects only exceeded placebo rates by one or two percentage points, so irbesartan is generally a well-tolerated medication overall.
How Medications Can Cause Hair Loss
When a medication does trigger hair loss, the most common mechanism is called telogen effluvium. Your hair grows in cycles: an active growth phase, a transitional phase, and a resting phase (telogen). Normally, only about 10% of your hair is in the resting phase at any given time. Certain drugs can push a larger proportion of hair follicles into this resting phase prematurely, which leads to noticeable shedding weeks or months later.
This type of hair loss typically appears one to three months after starting a new medication, because that’s how long it takes for the disrupted hair cycle to produce visible thinning. The shedding is usually diffuse, meaning it happens across the whole scalp rather than in patches. It can also occasionally affect body hair. The important thing to know is that telogen effluvium from medication is almost always temporary. Once you stop the drug, normal hair cycling resumes.
Recovery After Stopping a Medication
If you suspect irbesartan or any other medication is contributing to hair thinning, the typical recovery timeline after discontinuation is roughly six to nine months. The resting phase of hair naturally lasts three to six months, so follicles that were pushed into that phase need time to complete the cycle and begin growing again. You may start to see new growth within six months, but it can take longer for your overall hair volume to look and feel normal, especially if your hair is long.
In most cases, drug-induced hair loss is fully reversible. Permanent hair loss from medications is rare. You may notice changes in hair texture, color, or thickness during the regrowth period, but these differences generally resolve over time as well.
Blood Pressure Drug Classes and Hair Loss Risk
Irbesartan belongs to a class called angiotensin II receptor blockers (ARBs). As a group, ARBs are generally not associated with hair loss. They work by blocking a hormone that tightens blood vessels, and this mechanism doesn’t have a known pathway for disrupting hair growth.
Among blood pressure medications, beta-blockers and ACE inhibitors have slightly more documented associations with hair thinning, though even for those classes the incidence is low. Case reports have linked individual ACE inhibitors to alopecia, but it remains an uncommon side effect rather than a frequent one. Calcium channel blockers (like amlodipine) and thiazide diuretics (like hydrochlorothiazide) are also generally not linked to hair loss.
If you’re experiencing noticeable hair shedding while taking irbesartan, it’s worth considering other potential causes before attributing it to the medication. Thyroid disorders, iron deficiency, stress, hormonal changes, and nutritional gaps are all common triggers for telogen effluvium. Starting any new medication around the same time, even one unrelated to blood pressure, could also be responsible. A healthcare provider can help sort through the timing and rule out other contributors before making a medication change, since stable blood pressure control matters and switching drugs carries its own adjustment period.

